Avastin filed for lung cancer in Japan
November 27th, 2008
Chugai (Roche) has filed a submission in Japan for the approval of Avastin (bevacizumab) for the additional indication of non-small cell lung cancer.
November 27th, 2008
Chugai (Roche) has filed a submission in Japan for the approval of Avastin (bevacizumab) for the additional indication of non-small cell lung cancer.
© Copyright 2009 Bonnie J Addario Lung Cancer Foundation. All Rights Reserved.
601 4th Street Suite 215 | San Francisco, CA 94107 | 415.357.1278 ph | info@lungcancerfoundation.org